150 related articles for article (PubMed ID: 22335041)
1. Conservative management of young women with endometrial carcinoma or complex atypical hyperplasia: report of three cases and literature review.
Karimi-Zarchi M; Mousavi AS; Behtash N; Chiti Z; Bokaie M
Eur J Gynaecol Oncol; 2011; 32(6):695-8. PubMed ID: 22335041
[TBL] [Abstract][Full Text] [Related]
2. Fertility-Sparing Treatment of Early Endometrial Cancer and Complex Atypical Hyperplasia in Young Women of Childbearing Potential.
Pronin SM; Novikova OV; Andreeva JY; Novikova EG
Int J Gynecol Cancer; 2015 Jul; 25(6):1010-4. PubMed ID: 25950126
[TBL] [Abstract][Full Text] [Related]
3. Fertility-sparing treatment of endometrial cancer precursors among young women: a reproductive point of view.
Ricciardi E; Maniglio P; Frega A; Marci R; Caserta D; Moscarini M
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1934-7. PubMed ID: 23242719
[TBL] [Abstract][Full Text] [Related]
4. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
[TBL] [Abstract][Full Text] [Related]
5. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
6. Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy.
Penner KR; Dorigo O; Aoyama C; Ostrzega N; Balzer BL; Rao J; Walsh CS; Cass I; Holschneider CH
Gynecol Oncol; 2012 Mar; 124(3):542-8. PubMed ID: 22079678
[TBL] [Abstract][Full Text] [Related]
7. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review.
Gunderson CC; Fader AN; Carson KA; Bristow RE
Gynecol Oncol; 2012 May; 125(2):477-82. PubMed ID: 22245711
[TBL] [Abstract][Full Text] [Related]
8. Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome.
Kaku T; Yoshikawa H; Tsuda H; Sakamoto A; Fukunaga M; Kuwabara Y; Hataeg M; Kodama S; Kuzuya K; Sato S; Nishimura T; Hiura M; Nakano H; Iwasaka T; Miyazaki K; Kamura T
Cancer Lett; 2001 Jun; 167(1):39-48. PubMed ID: 11323097
[TBL] [Abstract][Full Text] [Related]
9. Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and/or complex hyperplasia with atypia.
Lowe MP; Cooper BC; Sood AK; Davis WA; Syrop CH; Sorosky JI
Gynecol Oncol; 2003 Dec; 91(3):569-72. PubMed ID: 14675678
[TBL] [Abstract][Full Text] [Related]
10. Endometrial adenocarcinoma in young patients: evaluation and fertility-preserving treatment.
Benshushan A
Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):132-7. PubMed ID: 15541846
[TBL] [Abstract][Full Text] [Related]
11. Fertility preserving management of early endometrial cancer in a patient cohort at the department of women's health at the university of Tuebingen.
Andress J; Pasternak J; Walter C; Kommoss S; Krämer B; Hartkopf A; Brucker SY; Schönfisch B; Steinmacher S
Arch Gynecol Obstet; 2021 Jul; 304(1):215-221. PubMed ID: 33606091
[TBL] [Abstract][Full Text] [Related]
12. [Application of endometrial sampling device during the follow-up visit for the conservative treatment of endometrial cancer].
Zhou R; Shen DH; Wang CH; Geng J; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):896-8. PubMed ID: 24495680
[TBL] [Abstract][Full Text] [Related]
13. Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer.
Yang B; Xu Y; Zhu Q; Xie L; Shan W; Ning C; Xie B; Shi Y; Luo X; Zhang H; Chen X
Gynecol Oncol; 2019 Apr; 153(1):55-62. PubMed ID: 30674421
[TBL] [Abstract][Full Text] [Related]
14. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
Cao DY; Yu M; Yang JX; Shen K; Huang HF; Cheng NH; Sun ZY; Deng CY; Yu Q; He FF
Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):519-22. PubMed ID: 24284224
[TBL] [Abstract][Full Text] [Related]
15. [Fertility-sparing management of endometrial cancer and atypical hyperplasia].
Gonthier C; Trefoux-Bourdet A; Luton D; Koskas M
Gynecol Obstet Fertil Senol; 2017 Feb; 45(2):112-118. PubMed ID: 28368791
[TBL] [Abstract][Full Text] [Related]
16. Efficacies and pregnant outcomes of fertility-sparing treatment with medroxyprogesterone acetate for endometrioid adenocarcinoma and complex atypical hyperplasia: our experience and a review of the literature.
Ohyagi-Hara C; Sawada K; Aki I; Mabuchi S; Kobayashi E; Ueda Y; Yoshino K; Fujita M; Tsutsui T; Kimura T
Arch Gynecol Obstet; 2015 Jan; 291(1):151-7. PubMed ID: 25118836
[TBL] [Abstract][Full Text] [Related]
17. Atypical endometrial hyperplasia in an 18-year-old woman.
Agorastos T; Vaitsi V; Vakiani A; Dinas K; Bontis J
Arch Gynecol Obstet; 2003 Feb; 267(4):252-5. PubMed ID: 12592432
[TBL] [Abstract][Full Text] [Related]
18. [Hormone therapy alone for pre-cancerous conditions and early endometrial cancer: pros and cons].
Novikova OV; Andreeva IuIu; Novikova EG; Vostrov AN; Pronin SM; Rubtsova NA; Danilova NV; Lozovaia IuA; Podtetenev DV
Vopr Onkol; 2014; 60(3):306-12. PubMed ID: 25033681
[TBL] [Abstract][Full Text] [Related]
19. Management of endometrial precancers.
Trimble CL; Method M; Leitao M; Lu K; Ioffe O; Hampton M; Higgins R; Zaino R; Mutter GL;
Obstet Gynecol; 2012 Nov; 120(5):1160-75. PubMed ID: 23090535
[TBL] [Abstract][Full Text] [Related]
20. [Young women with atypical endometrial hyperplasia or endometrial adenocarcinoma stage I: will conservative treatment allow pregnancy? Results of a French multicentric survey].
Le Digabel JF; Gariel C; Catala L; Dhainaut C; Madelenat P; Descamps P
Gynecol Obstet Fertil; 2006 Jan; 34(1):27-33. PubMed ID: 16406735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
